I know you know the financing they have in place but here is a review of it if you forgot
Amarantus BioSciences Announces Close of $10M
Equity Funding Facility with Centurion Private
Equity, LLC
SUNNYVALE, CA - October 13, 2011 – Amarantus Biosciences, Inc. (OTCBB: AMBS) a
biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic
protein that addresses an underlying form of cell death known as apoptosis, announced
today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC
(“Centurion”). The Company will have the ability to draw down on this facility over the course
of the next 36 months in tranches of up $750,000